Basseterre, St. Kitts, February 12, 2021 (SKNIS): St. Kitts & Nevis’ Chief Medical Officer, Dr. Hazel Laws, said that the procurement in the first instance of 21, 600 doses of the COVID-19 Vaccine, will provide coverage for 20 percent of the national population.
She said this during the National Emergency Operations Center (NEOC) COVID-19 Press Briefing on February 10. “The doses are the product of AstraZeneca and Oxford University vaccines,” she said.
“The start date for delivery can be as early as mid to late February, however, there were some conditions where the specific date of delivery would be dependent on the WHO Emergency Use List Approval Process and some other steps which include our own implementation of our vaccination plan and our regulatory preparedness,” said Dr. Laws.
“It specified that about 25 – 35% of the amount will be supplied in the first quarter and about 65-75% in the second quarter,” she said.
“The data from the clinical trials suggest that it offers a 62 percent efficacy, but the clinical trials have since found that the vaccine had an efficacy of about 82 percent when two doses were given 12 weeks apart,” said Dr. Laws. -30-
Thursday, April 2
Trending
- NATIONAL DEVELOPMENT PLANNING FRAMEWORK POSITIONED AS TRANSFORMATIVE BLUEPRINT FOR THE FUTURE
- SENATOR PHILLIP GIVES FULL SUPPORT FOR THE ESTABLISHMENT OF A SOVEREIGN WEALTH AND RESILIENCE FUND IN SAINT KITTS AND NEVIS
- Important Notice – Basseterre High School Job Fair
- Strict Measures in Place to Protect Children and Vulnerable Groups from Cannabis Exposure
- St. Kitts and Nevis First in Caribbean to Recognize Rastafarian Faith in Law
- Attorney General Wilkin Explains Why Cannabis Cannot Be Fully Legalized Amid Global Banking Risks
- Cannabis Must Be Introduced “Responsibly” to Protect Economy and People, Says Prime Minister Drew
- CONSUMERS URGED TO REDUCE $28M ARREARS FOR WATER SERVICE AS GOVERNMENT EXPANDS SUPPLY INFRASTRUCTURE

